Active management of the childbirth with sublingual Misoprostol: a clinical controlled trial at Hospital de Maternidad Rafael Calvo.
DOI:
https://doi.org/10.18597/rcog.655Keywords:
Misoprostol, oxitocina, metil-ergonovina, laborAbstract
OBJECTIVES: The objective of the present study is to determine the security, efficacy and costs of the sublingual Misoprostol, in the active management of the third period of labor.
MATERIALS AND METHODS: In a prospective study, randomized, controlled, where they are distributed 75 patient in three groups of 25 patient: A. Sublingual Misoprostol, B. Oxitocina IV, C. Metil-ergonovina after delivery of the placenta. Blood loss was estimated during the first hour after the vaginal delivery and difference in the third period of labor were measured. The cost of the drugs and materials used in each group was valued, the behavior of the vital signs before and after the childbirth and the collateral effects of the drug in each one of the groups.
RESULTS: Blood loss during the first hour of vaginal delivery was from 389cc ± 271.7 in the group of Misoprostol Vs 467cc ± 427.5 in the group of Oxitocina; Vs 546.8 ± 338.5 for the group of Metil-ergonovina after delivery of the placenta. Being these outputs statistically significant p< 0.01. The time of childbirth was minor in the group of Misoprostol 308seg ± 57 Vs 362seg ± 162.3 with Oxitocina, Vs 557 ± [seg] 256.2 (p< 0.05). The costs with Misoprostol were $500 Vs $8,000 with Oxitocina and $2,000 with Metil-ergonovina. There were not collateral effects in any of the groups.
CONCLUSION: The Use of 50mcgr of sublingual Misoprostol is sure, effective and economical in the third period of the labor.
Author Biographies
William Angarita Peñaranda
Orlando Borré Arrieta
Benjamín Rodríguez Yances
References
Kwast BE. Postpartum haemorrhage: Its contribution to maternal mortality. Midwifery 1991;7:64-70.
Berg CJ, Atrash HK, Konin LM, Tucker M. Pregnancy related mortality in the United States, 1987-1990. Obstet Gynecol 1996;88:167.
Prendiville WJ, Elboume DR, McDonals. Active versus expectant management of the third stage of Labour. In: Nelson JP, Crouther CA, Hodnett E, Hofmeyr GJ, Keirse MJ, editors. Pregnancy and child birth module of the Cochrane database of systematic reviews. The Cochrane Collaboration: Issue 1. Oxford: Update software; 1997.
Walley RL, Wilson JB, Crane JM, Matthews K, Sawyer E, Hutchens D. A double-blind placebo controlled randomized trial of misoprostol and oxytocin in the management of the third stage of labour. BJOG 2000;107:1111-5.
Surbek DV, Fehr PM, Hosli I, Horegreve WH. Oral Misoprostol for Third Stage of labor. A Randomized Placebo-Controlled Trial. Obstet Gynecol 1999;94:255-7.
Bamigboye AA, Hofmyr J, Merrell DA. Rectal Misoprostol in the prevention of postpartum hemorrhage: a placebo controlled trial. Am J. Obstet. Gynecol 1998;179:1043-6.
Gómez I, Pinzón W, Rueda R, Sarmiento A. Uso del Misoprostol intrarectal en el tratamiento de la atonía uterina. Rev Colomb Obstet Ginecol 1999;50:253-4.
Alva J, Alva H, Canales J. Eficacia del Misoprostol vía sublingual comparado con vía oral en el tercer período del parto. Rev Ginecol Obst Peruana 2000. Vol XLVI Nº 1.
Angarita W, Rodríguez B, Borré O. Prevención de la hemorragia postcesárea con Misoprostol sublingual Vs Oxitocina. Estudio presentado en el XXII Congreso Colombiano de Ginecología y Obstetricia. Cartagena 2000. Publicado en Libro Premio AFIDRO a la investigación médica 2000.
Hofmeyer GJ, Nikoden VC, de Jager M, Gelban BR. A randomized placebo controlled trial of oral Misoprostol in the third stage of labour. Br . J Obstet Gynecol 1998;105:971-5.
El-RefaeyH, Nooh R, O'Brien P, Abadía M, Geary M, Valde J, Rodeck C. The Misoprostol Third stage of labour study. A randomized controlled comparison between orally administered Misoprostol and standard management . B.JOG 2000;107: 1104-10.
Cook CM, Sporiet EB, Murray H. A randomized clinical trial comparing oral Misoprostol with syntetic oxitocin or syntometrine in the third stage of labour. Aust N Z J Obstet Gynecol 1999;39:414-9.
Amant F, Spitz B, Timmerman D, Corremans A, Van Asshe FA,. Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: A double blind randomized trial. Br J Obstet Gynecol 1999;106:1066-70.
Borré O, Rodríguez B, Mendivil C, Angarita W, Borré J. Inducción del trabajo de parto con Misoprostol Vs Oxitocina. Rev Colomb Obstet Ginecol 2000;51:8-11.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
